Position in BLLN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,472,939
New position
Shares Held
18,659
first reported quarter
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 84%
Shared 0%
None 16%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Russell Investments Group, Ltd. holds $943,350,010 across 33 Diagnostics & Research names. BLLN ranks #26 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
955,909 | $181,240,338 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
303,653 | $149,254,552 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
96,524 | $121,736,063 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
201,694 | $113,329,834 | |
| 5 | A |
Agilent Technologies, Inc.
|
673,483 | $76,763,586 | |
| 6 | ICLR |
Icon PLC
|
514,306 | $56,913,096 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
187,078 | $31,904,278 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
62,750 | $30,131,914 |
All Filings in BLLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,472,939 | 18,659 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||